title: GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.
abstract: In situ hybridization (ISH) enables the visualization of specific mRNA for pituitary hormones. Our collection consists of 40 surgically removed pituitary adenomas that were classified as follicle stimulating hormone/luteinizing hormone (FSH/LH) cell adenomas by structure and by immunostaining (IH) for all pituitary hormones. All forty adenomas were regarded as clinically inactive. The aim of our study was to examine nonfunctioning adenomas by ISH for demonstration of mRNAs for all pituitary hormones. The results were compared with proliferation markers, invasiveness and clinical data. ISH detected signals for all pituitary hormones at a range of 30% for prolactin (PRL) to 85% for proopiomelanocortin (POMC). mRNA for beta-FSH was detected in 70% and beta-LH mRNA in 43% of adenomas. Thirty-three percent of adenomas revealed negative mRNA detection for beta-LH but positive hormone content. The majority of adenomas (75%) expressed more than two mRNAs simultaneously, mostly the combination of POMC mRNA together with beta-FSH mRNA and one to four others. Comparison with clinical data showed no significant differences except for one adenoma with a high Ki-67 index (> 2.1% positive nuclei). This adenoma showed very high signals for PRL and beta-TSH mRNA.
authors.affiliation: Institute of Pathology, Marienkrankenhaus, Alfredstr. 9, D-22087 Hamburg, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Münscher
authors.forename: M
authors.initials: M
authors.lastname: Schmid
authors.forename: W
authors.initials: W
authors.lastname: Saeger
authors.forename: S
authors.initials: S
authors.lastname: Schreiber
authors.forename: D K
authors.initials: DK
authors.lastname: Lüdecke
mesh_terms: D000236:Adenoma / Q000737:chemistry* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005640:Follicle Stimulating Hormone / Q000235:genetics; D037201:Follicle Stimulating Hormone, beta Subunit; D006065:Gonadotropins, Pituitary / Q000032:analysis* / Q000235:genetics*; D019382:Human Growth Hormone / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007986:Luteinizing Hormone / Q000235:genetics; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000737:chemistry* / Q000473:pathology; D011333:Pro-Opiomelanocortin / Q000235:genetics; D011388:Prolactin / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis*; D013972:Thyrotropin / Q000235:genetics
chemical_list: D037201:Follicle Stimulating Hormone, beta Subunit; D006065:Gonadotropins, Pituitary; D012333:RNA, Messenger; D019382:Human Growth Hormone; D011333:Pro-Opiomelanocortin; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin